AEGiS-IRIN: New HIV/Aids Monitoring Test Could Cut Costs UN Integrated Regional Information NetworkImportant note: Information in this article was accurate in 2003. The state of the art may have changed since the publication date.
Click here to return to UN Integrated Regional Information Network main menu
DonateNow




New HIV/Aids Monitoring Test Could Cut Costs

Integrated Regional Information Networks - November 4, 2003


Scientists have come up with a faster and cheaper HIV/AIDS monitoring technique which could make treatment more affordable in developing countries.

A study conducted by researchers in Zambia's University Teaching Hospital and the University College in London, has found that spots of dried blood, filter paper and inexpensive commercially available chemicals, could be developed into a "field-friendly alternative" to the sophisticated technology required to carry out CD4 count testing. A CD4 count measures the strength of the immune system.

Existing guidelines for managing patients on antiretroviral (ARV) therapy use viral load and CD4 count testing to measure the impact of ARVs on the patient's health.

Although ARVs are increasingly becoming available in African countries at reduced prices, the high cost of monitoring equipment remains one of the biggest obstacles.

In Zambia, where the government has announced plans to treat up to 10,000 HIV-positive people in state hospitals and clinics, a CD4 count test can cost up to US $40.

"But the equipment for measuring CD4 counts is not widely available and is limited to tertiary institutions and private hospitals," Dr Peter Mwaba of the University Teaching Hospital, and one of the study's researchers, told IRIN.

According to the study findings published in the UK-based Lancet Journal, "the present gold standard" for CD4 count tests was the flow cytometer - a machine which counts cells as they go through a laser beam.

"There are a lot of tests that are used to measure CD4 count and viral load. But with all these tests, fresh samples of blood are required. This is not practical in countries like mine where there are no laboratory facilities in rural areas," Mwaba commented.

Researchers at the University Teaching Hospital took blood spots from 42 HIV-positive patients and put them on filter paper, which was allowed to dry.

The test samples were then sent to a central clinic without refrigeration.

The blood spots were analysed using a simple test involving antibodies that latched onto CD4 cells. The bound antibodies caused a colour change in a solution made from the dried blood: a deeper colour equaled a higher cell count.

The report found that filter papers offered "an attractive alternative to use of fresh whole blood. Once the samples have dried, the filter papers can be stored at room temperatures for long periods before being batched and sent to a central laboratory."

"The results compared very well to the [flow] cytometer - there were some very slight variations but these won't change the meaning of the result," Mwaba noted.

He pointed out, however, that the new technique still needed to be refined. "We can't get excited on 42 patients, we are planning on expanding the tests and we are looking at a larger trials involving about 1,000 patients."

Nevertheless, the implications for African countries considering the roll-out of ARVs can not be ignored. A CD4 count using this new method could cost up to US $5 in the developing world and patients receiving treatment could also be managed properly, he said.


031104
IR031104


Copyright © 2003 - Integrated Regional Information Networks (IRIN). Reproduction of this article (other than one copy for personal reference) must be cleared through the Integrated Regional Information Network. .

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980 – 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .